Westra P, Houwertjes M C, de Lange A R, Scaf A H, Hindriks F R, Agoston S
Br J Anaesth. 1980 Aug;52(8):747-57. doi: 10.1093/bja/52.8.747.
Pancuronium, Org 6368 and gallamine were compared in control cats and in cats with experimental cholestasis. A decrease in the plasma clearance and a prolongation of neuromuscular blockade with Org 6368 and pancuronium were found in the latter; no significant difference was detected in the biotransformation pattern of Org 6368 and pancuronium compared with controls. Inhibition of hepatic uptake of Org 6368 and pancuronium in extrahepatic cholestasis might explain the significant alterations in the pharmacokinetics of the two steroid neuromuscular blocking drugs. The pharmacokinetics of gallamine were normal during cholestasis. The results suggest that, under pathological conditions involving increased plasma concentrations of bile salts, neuromuscular blocking agents that are cleared from the plasma by the liver may have an impaired hepatic uptake and consequently a prolonged duration of action.
在对照猫和实验性胆汁淤积猫中对泮库溴铵、Org 6368和加拉明进行了比较。在实验性胆汁淤积猫中发现Org 6368和泮库溴铵的血浆清除率降低,神经肌肉阻滞时间延长;与对照组相比,未检测到Org 6368和泮库溴铵的生物转化模式有显著差异。肝外胆汁淤积时肝脏对Org 6368和泮库溴铵摄取的抑制可能解释了这两种甾体类神经肌肉阻滞药物药代动力学的显著改变。胆汁淤积期间加拉明的药代动力学正常。结果表明,在涉及血浆胆汁盐浓度升高的病理条件下,经肝脏从血浆中清除的神经肌肉阻滞剂可能存在肝脏摄取受损,从而作用时间延长。